These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Genomic instability and recurrent breakpoints are main cytogenetic findings in Hodgkin's disease. Falzetti D; Crescenzi B; Matteuci C; Falini B; Martelli MF; Van Den Berghe H; Mecucci C Haematologica; 1999 Apr; 84(4):298-305. PubMed ID: 10190942 [TBL] [Abstract][Full Text] [Related]
6. Cytogenetic studies of Hodgkin's disease. Analysis of involved lymph nodes from 12 patients. Dennis TR; Stock AD; Winberg CD; Sheibani K; Rappaport H Cancer Genet Cytogenet; 1989 Feb; 37(2):201-8. PubMed ID: 2702619 [TBL] [Abstract][Full Text] [Related]
7. Cytogenetic studies in untreated Hodgkin's disease. Tilly H; Bastard C; Delastre T; Duval C; Bizet M; Lenormand B; Daucé JP; Monconduit M; Piguet H Blood; 1991 Mar; 77(6):1298-304. PubMed ID: 2001453 [TBL] [Abstract][Full Text] [Related]
8. Histogenesis of Hodgkin's disease: possible insights from a comparison with lymphomatoid papulosis. Kadin ME Hum Pathol; 1987 Nov; 18(11):1085-8. PubMed ID: 3500105 [TBL] [Abstract][Full Text] [Related]
9. The localization of Hodgkin's disease in lymph nodes. A study with immunohistological, enzyme histochemical and rosetting techniques on frozen sections. Poppema S; Elema JD; Halie MR Int J Cancer; 1979 Nov; 24(5):532-40. PubMed ID: 93582 [TBL] [Abstract][Full Text] [Related]
10. Immunological markers of peripheral blood and lymph node lymphocytes in Hodgkin's disease. González M; Hernández F; San Miguel JF; Moraleda JM; Caballero MD; López Borrasca A Neoplasma; 1985; 32(2):191-8. PubMed ID: 4000308 [TBL] [Abstract][Full Text] [Related]
11. Prognostic implications of karyotype and morphology in patients with non-Hodgkin's lymphoma. Kaneko Y; Rowley JD; Variakojis D; Haren JM; Ueshima Y; Daly K; Kluskens LF Int J Cancer; 1983 Dec; 32(6):683-92. PubMed ID: 6654522 [TBL] [Abstract][Full Text] [Related]
12. The patterns of IL2, IFN-gamma, IL4 and IL5 gene expression in Hodgkin's disease and reactive lymph nodes are similar. Serrano D; Ghiotto F; Roncella S; Airoldi I; Cutrona G; Truini M; Burgio VL; Baroni CD; Ferrarini M; Pistoia V Haematologica; 1997; 82(5):542-9. PubMed ID: 9407718 [TBL] [Abstract][Full Text] [Related]
13. Some characteristics of a human cell line (AICHI-4) established from tumorous lymphatic tissue of Hodgkin's disease. Ito Y; Shiratori O; Kurita S; Takahashi T; Kurita Y; Ota K J Natl Cancer Inst; 1968 Dec; 41(6):1367-75. PubMed ID: 5728341 [No Abstract] [Full Text] [Related]
14. T-lymphocyte subpopulations in B-cell-derived non-Hodgkin's lymphomas and Hodgkin's disease. Knowles DM; Halper JP; Jakobiec FA Cancer; 1984 Aug; 54(4):644-51. PubMed ID: 6234982 [TBL] [Abstract][Full Text] [Related]
15. Cytogenetic studies in malignant lymphomas: a study of 8 cases. Coutinho V; Bottura C; Falcao RP Br J Cancer; 1971 Dec; 25(4):789-801. PubMed ID: 4947349 [TBL] [Abstract][Full Text] [Related]
16. Lymphocyte populations in lymph nodes in different histological types of Hodgkin's disease in children. Pituch-Noworolska A; Drabik G; Kacińska E; Klekawka T Acta Haematol; 2004; 112(3):129-35. PubMed ID: 15345894 [TBL] [Abstract][Full Text] [Related]
17. Chromosomes in Hodgkin's disease. Rowley JD Cancer Treat Rep; 1982 Apr; 66(4):639-43. PubMed ID: 7074634 [TBL] [Abstract][Full Text] [Related]
18. The T and B lymphocyte content of lymph nodes and spleen in Hodgkin's disease. Stathopoulos G; Papamichail M; Peckham MJ; Davies AJ; Holborow EJ Br J Exp Pathol; 1977 Dec; 58(6):712-6. PubMed ID: 305255 [TBL] [Abstract][Full Text] [Related]
19. Chromosome complement of lymph node cells in Hodgkin's disease. Whitelaw DM Can Med Assoc J; 1969 Jul; 101(2):74-81. PubMed ID: 4893675 [No Abstract] [Full Text] [Related]
20. Acute non-lymphocytic leukemia in a lymph node concurrent with Hodgkin's lymphoma. Silberman S; Messmore HL Ann Clin Lab Sci; 1985; 15(1):83-7. PubMed ID: 3970520 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]